Advisors Asset Management, Inc. Illumina, Inc. Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 1,047 shares of ILMN stock, worth $139,847. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,047

Previous 1,154 9.27%

Holding current value

$139,847

Previous $120,000 13.33%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$105.28 - $135.9 $11,264 - $14,541	-107 Reduced 9.27%	1,047 $136,000
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $22,837 - $30,186	-226 Reduced 16.38%	1,154 $120,000
Q1 2024 May 14, 2024	SELL	$127.73 - $147.2 $8,302 - $9,568	-65 Reduced 4.5%	1,380 $189,000
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $10,485 - $16,105	-113 Reduced 7.25%	1,445 $201,000
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $535,615 - $679,396	-2,920 Reduced 65.21%	1,558 $292,000
Q1 2023 May 12, 2023	SELL	$193.75 - $232.55 $66,068 - $79,299	-341 Reduced 7.08%	4,478 $1.04 Million
Q4 2022 Feb 13, 2023	SELL	$187.24 - $242.74 $639,237 - $828,714	-3,414 Reduced 41.47%	4,819 $974,000
Q3 2022 Nov 08, 2022	SELL	$177.23 - $227.44 $655,396 - $841,073	-3,698 Reduced 30.99%	8,233 $1.57 Million
Q2 2022 Aug 08, 2022	SELL	$181.58 - $368.0 $699,264 - $1.42 Million	-3,851 Reduced 24.4%	11,931 $2.2 Million
Q1 2022 May 17, 2022	SELL	$303.87 - $423.8 $524,783 - $731,902	-1,727 Reduced 9.86%	15,782 $5.51 Million
Q4 2021 Feb 15, 2022	BUY	$347.28 - $421.83 $132,660 - $161,139	382 Added 2.23%	17,509 $6.66 Million
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $874,495 - $1.13 Million	2,156 Added 14.4%	17,127 $6.95 Million
Q2 2021 Jul 30, 2021	BUY	$372.84 - $481.5 $1.07 Million - $1.38 Million	2,875 Added 23.77%	14,971 $7.08 Million
Q1 2021 May 07, 2021	SELL	$361.28 - $504.76 $716,779 - $1 Million	-1,984 Reduced 14.09%	12,096 $4.65 Million
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $846,781 - $1.07 Million	-2,893 Reduced 17.04%	14,080 $5.21 Million
Q3 2020 Nov 16, 2020	SELL	$268.51 - $400.74 $1.24 Million - $1.85 Million	-4,614 Reduced 21.37%	16,973 $5.25 Million
Q2 2020 Aug 12, 2020	SELL	$256.46 - $373.01 $1.07 Million - $1.55 Million	-4,156 Reduced 16.14%	21,587 $8 Million
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $2.14 Million - $3.43 Million	-10,232 Reduced 28.44%	25,743 $7.03 Million
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $1.43 Million - $1.66 Million	-4,947 Reduced 12.09%	35,975 $11.9 Million
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $1.73 Million - $2.45 Million	-6,485 Reduced 13.68%	40,922 $12.4 Million
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $399,484 - $489,271	-1,329 Reduced 2.73%	47,407 $17.5 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $400,132 - $471,492	1,468 Added 3.11%	48,736 $15.1 Million
Q4 2018 Jan 31, 2019	BUY	$272.46 - $366.54 $983,308 - $1.32 Million	3,609 Added 8.27%	47,268 $14.2 Million
Q3 2018 Nov 15, 2018	BUY	$279.04 - $367.06 $504,783 - $664,011	1,809 Added 4.32%	43,659 $16 Million
Q2 2018 Aug 22, 2018	BUY	$228.17 - $292.07 $4.92 Million - $6.29 Million	21,542 Added 106.08%	41,850 $11.7 Million
Q2 2018 Aug 15, 2018	SELL	$228.17 - $292.07 $3.08 Million - $3.94 Million	-13,500 Reduced 39.93%	20,308 $11.7 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $1.22 Million - $1.47 Million	5,801 Added 20.71%	33,808 $7.71 Million
Q4 2017 Feb 13, 2018	BUY	$202.23 - $230.03 $1.22 Million - $1.39 Million	6,031 Added 27.44%	28,007 $6.12 Million
Q3 2017 Nov 07, 2017	BUY	$172.3 - $213.93 $3.79 Million - $4.7 Million	21,976	21,976 $4.38 Million

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Illumina, Inc. Transaction History